The Farnesoid X Receptor (FXR) as modulator of bile acid metabolism

scientific article published in December 2004

The Farnesoid X Receptor (FXR) as modulator of bile acid metabolism is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1040297710
P356DOI10.1023/B:REMD.0000045103.00467.9A
P698PubMed publication ID15486464

P50authorFolkert KuipersQ53606987
Bart StaelsQ28360345
P2093author name stringFolkert Kuipers
Ekkehard Sturm
Thierry Claudel
P2860cites workIdentification of a novel gene family encoding human liver-specific organic anion transporter LST-1Q22009932
Identification of a nuclear receptor for bile acidsQ22010058
Bile acids: natural ligands for an orphan nuclear receptorQ22010063
Molecular basis for feedback regulation of bile acid synthesis by nuclear receptorsQ24290397
Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesisQ24305561
Identification of farnesoid X receptor beta as a novel mammalian nuclear receptor sensing lanosterolQ24540997
Functional expression cloning and characterization of the hepatocyte Na+/bile acid cotransport systemQ24559977
Comparison of complete nuclear receptor sets from the human, Caenorhabditis elegans and Drosophila genomesQ24803733
A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXRQ27641086
Structural basis for bile acid binding and activation of the nuclear receptor FXRQ27641089
Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasisQ28139039
Correlation of farnesoid X receptor coactivator recruitment and cholesterol 7alpha-hydroxylase gene repression by bile acidsQ28141468
FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activityQ28179104
Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expressionQ28191058
Endogenous bile acids are ligands for the nuclear receptor FXR/BARQ28198990
The enzymes, regulation, and genetics of bile acid synthesisQ28204726
Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pumpQ43899918
Identification of gene-selective modulators of the bile acid receptor FXR.Q44259003
Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membraneQ44527593
Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated miceQ44569549
Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestineQ44583396
Purification and characterization of cholyl-CoA: taurine N-acetyltransferase from the liver of domestic fowl (Gallus gallus)Q44695916
Expression cloning and characterization of the hamster ileal sodium-dependent bile acid transporter.Q48085781
Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.Q52541251
The synthesis of taurocholic and glycocholic acids by preparations of human liver. II. An analysis of the stimulating effect of the L fraction.Q53680056
Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.Q54017726
Molecular pathogenesis of cholestasis.Q54344101
Bile acid sulfotransferase I from rat liver sulfates bile acids and 3-hydroxy steroids: purification, N-terminal amino acid sequence, and kinetic properties.Q55059826
Cytokines tumor necrosis factor and interleukin-6 in experimental biliary obstruction in miceQ68134831
In situ localization of the hepatocytic Na+/Taurocholate cotransporting polypeptide in rat liverQ72800609
Hepatic basolateral sodium-dependent-bile acid transporter expression in two unusual cases of hypercholanemia and in extrahepatic biliary atresiaQ73319943
Farnesoid X receptor responds to bile acids and represses cholesterol 7alpha-hydroxylase gene (CYP7A1) transcriptionQ73643139
Molecular mechanisms of cholestasis: causes and consequences of impaired bile formationQ77451209
Farnesoid X Receptor Regulates Bile Acid-Amino Acid ConjugationQ28204827
The amino acid residues asparagine 354 and isoleucine 372 of human farnesoid X receptor confer the receptor with high sensitivity to chenodeoxycholateQ28217144
Identification of a nuclear receptor that is activated by farnesol metabolitesQ28302684
Liver receptor homologue-1 mediates species- and cell line-specific bile acid-dependent negative feedback regulation of the apical sodium-dependent bile acid transporterQ28513496
Dehydroepiandrosterone sulfotransferase gene induction by bile acid activated farnesoid X receptorQ28570159
The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liverQ28571688
Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4Q28590891
Enterohepatic circulation of bile salts in farnesoid X receptor-deficient mice: efficient intestinal bile salt absorption in the absence of ileal bile acid-binding proteinQ28593082
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesisQ29617241
Identification of a chemical tool for the orphan nuclear receptor FXR.Q31431724
Nuclear receptor regulation of cholesterol and bile acid metabolism.Q33796274
Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimerQ33876356
Intracellular transport of bile acidsQ33944790
Transcriptional regulation of the human sterol 12alpha-hydroxylase gene (CYP8B1): roles of heaptocyte nuclear factor 4alpha in mediating bile acid repressionQ34089245
Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasisQ34118792
6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity.Q34143282
Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisitedQ34146325
Glucuronidation of hyodeoxycholic acid in human liver. Evidence for a selective role of UDP-glucuronosyltransferase 2B4.Q34345008
Genes and cholestasis.Q34455645
Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response elementQ34790389
Bile acid regulation of hepatic physiology: III. Bile acids and nuclear receptorsQ35063226
Identification of the bile acid binding proteins in human serum by photoaffinity labelingQ36690966
Alternative splicing of the rat sodium/bile acid transporter changes its cellular localization and transport propertiesQ37273791
Rat cholangiocytes absorb bile acids at their apical domain via the ileal sodium-dependent bile acid transporterQ37375465
Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor.Q38300264
Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasisQ40271507
Retinoid X receptor (RXR) agonist-induced antagonism of farnesoid X receptor (FXR) activity due to absence of coactivator recruitment and decreased DNA bindingQ40678679
Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activationQ40694910
Bile acid induction of cytokine expression by macrophages correlates with repression of hepatic cholesterol 7alpha-hydroxylaseQ41737442
Enhanced expression of the human multidrug resistance protein 3 by bile salt in human enterocytes. A transcriptional control of a plausible bile acid transporterQ42511033
12 alpha-hydroxylase activity in human liver and its relation to cholesterol 7 alpha-hydroxylase activityQ43410713
Down-regulation of cholesterol 7alpha-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-Jun N-terminal kinase pathwayQ43559873
Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liverQ43563069
The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcpQ43662706
Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liverQ43662715
Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acidsQ43752389
P433issue4
P304page(s)319-326
P577publication date2004-12-01
P1433published inReviews in Endocrine and Metabolic DisordersQ15766899
P1476titleThe Farnesoid X Receptor (FXR) as modulator of bile acid metabolism
P478volume5

Reverse relations

cites work (P2860)
Q55843627A novel heterozygous NR1H4 termination codon mutation in idiopathic infantile cholestasis
Q34509231AKR1B7 is induced by the farnesoid X receptor and metabolizes bile acids
Q41964052An increased flux through the glucose 6-phosphate pool in enterocytes delays glucose absorption in Fxr-/- mice
Q89964111Baicalin Protects Against 17α-Ethinylestradiol-Induced Cholestasis via the Sirtuin 1/Hepatic Nuclear Receptor-1α/Farnesoid X Receptor Pathway
Q28085493Bile acid nuclear receptor FXR and digestive system diseases
Q43057268Bile acids increase hepatitis B virus gene expression and inhibit interferon-alpha activity
Q49722254Current therapies in alleviating liver disorders and cancers with a special focus on the potential of vitamin D.
Q34535765Effects of bile acids and the bile acid receptor FXR agonist on the respiratory rhythm in the in vitro brainstem medulla slice of neonatal Sprague-Dawley rats
Q46605391Exercising the nuclear option to treat cholestasis: CAR and PXR ligands
Q46897927FXR-mediated regulation of angiotensin type 2 receptor expression in vascular smooth muscle cells
Q90034560Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease
Q53259885Hepatology over the years.
Q59335763Hypothalamus-Pituitary-Adrenal Dysfunction in Cholestatic Liver Disease
Q37199631Mechanisms of disease: Inborn errors of bile acid synthesis
Q36060817Morphologic Damage of Rat Alveolar Epithelial Type II Cells Induced by Bile Acids Could Be Ameliorated by Farnesoid X Receptor Inhibitor Z-Guggulsterone In Vitro
Q64230670Nuclear Receptors in the Pathogenesis and Management of Inflammatory Bowel Disease
Q28390150Nutritional lipidomics: molecular metabolism, analytics, and diagnostics
Q42696407Pyrazinamide Induced Rat Cholestatic Liver Injury through Inhibition of FXR Regulatory Effect on Bile Acid Synthesis and Transport
Q46132296The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis
Q28587753The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice
Q28118770The nuclear receptor FXR is expressed in pancreatic beta-cells and protects human islets from lipotoxicity
Q39943758Transactivation of the hepatitis B virus core promoter by the nuclear receptor FXRalpha
Q38323598Transient impairment of the adaptive response to fasting in FXR-deficient mice
Q33236324Transport of fluorescent chenodeoxycholic acid via the human organic anion transporters OATP1B1 and OATP1B3.
Q39642788Upregulation of scavenger receptor class B type I expression by activation of FXR in hepatocyte

Search more.